Company intelligence / Profile preview

Phortas

Aachen, Nordrhein-Westfalen, Germanyphortas.com ↗

Ownership: Private
Development stage: Other

Overview

Phortas is an independent expert consultancy providing regulatory affairs, clinical management, and development consulting services to pharmaceutical, biotech companies, CROs, and academic institutions. They support clients across the full spectrum of drug development for drugs, biologics, combination products, medical devices—including specialty medicines such as orphan drugs and ATMPs—across multiple therapeutic areas.

Therapeutic areas: OncologyPulmonologyImmunologyHematologyDermatologyNeurologyCardiovascularOphthalmologyNephrology
Modalities: Small moleculeBiologicCombination productMedical device
Industry: Consulting

Partnerships

Works with SMEs in biotech/pharma sectorCollaborates with CROs and academic institutions as clients

Beyond the preview

Go deeper on Phortas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phortas.

Explore the full profile